Streetbeat News

CBDD

CBD of Denver Inc

Open

0.00

Mkt cap

2.1M

Volume

832K

High

0.00

P/E Ratio

-0.30

52-wk high

0.00

Low

0.00

Div yield

N/A

52-wk low

0.00

CBD of Denver reported an increase in Q3 2024 revenue to $763,450, up from $677,893 in Q3 2023. The company also provided updates on its spinoff and the German market following the Cannabis Act's implementation.

Portfolio Pulse from

November 10, 2024 | 3:45 pm

CBD of Denver, Inc. reported a 37.4% YoY increase in Q2 revenue to $1,002,240, slightly below expectations. The company is expanding into the German market, facing regulatory challenges. Operating expenses and salaries have decreased, indicating improved efficiency.

Portfolio Pulse from Jelena Martinovic

August 30, 2024 | 3:57 pm

CBD of Denver, Inc. (OTC:CBDD) projects $1.03 million in Q2 revenue, up from $720,000 in the same period of 2023. The company is exploring opportunities in the German market through its subsidiary Luxora, which has received positive engagement for a cannabis testing device. Despite challenges in its wholesale business, the company is focusing on higher-margin opportunities and recurring revenue. The German market is evolving with slow progress in cannabis club applications.

Portfolio Pulse from Nina Zdinjak

August 05, 2024 | 4:53 pm

CBD of Denver, Inc. (OTC:CBDD) is making strides in the German cannabis market, having excelled at the Mary Jane Berlin trade fair. The company showcased its products and tested its CheckMyWeed tool, projecting $300,000 in revenue for June 2024. They also engaged with potential cannabis club enthusiasts, collecting over 50 qualified leads.

Portfolio Pulse from Rolando García

July 01, 2024 | 7:19 pm

CBD of Denver, Inc. (OTC:CBDD) reported increased Q4 revenue, reaching $1.310 million, with Luxora contributing approximately $1.134 million and Libra 9 about $176,000. The company's growth is attributed to partnerships and market strategies, including a teleshopping partnership and trade show presence. Luxora's expansion in the European CBD wholesale market and potential entry into the German market are key growth drivers. The legalization of marijuana in Germany, which could impact Luxora, has been postponed to 2024. CBDD's stock rose 16.6667% to $0.0007 post-market on Wednesday.

Portfolio Pulse from Jelena Martinovic

December 28, 2023 | 4:02 pm

CBD of Denver Inc (OTCPK: CBDD) has announced the creation of Luxora Real Estate AG in Switzerland, with plans to invest in German commercial real estate. Luxora aims to raise 10 million CHF to purchase properties and convert them into indoor farming facilities for lease to cannabis clubs in Germany. The company has already targeted two properties in Berlin, aligning with upcoming cannabis regulations in July 2024. CBDD's shares were trading at $0.0007 at the time of the report.

Portfolio Pulse from Patricio Liddle

December 04, 2023 | 6:16 pm

German lawmakers are preparing to vote on a marijuana legalization measure, with the Health Minister optimistic about its implementation next year. The measure includes provisions for recreational use, cultivation, and social clubs. However, the Bundesrat, particularly Bavaria, may challenge the reform. U.S. and Canadian cannabis companies like Tilray Brands Inc., Aurora Cannabis Inc., and Curaleaf Holdings, Inc. are well-positioned to capitalize on the German market. CBD of Denver Inc. is expanding in Europe with plans for Cannabis Clubs in Germany. Organigram Holdings Inc. has a supply agreement with Sanity Group GmbH, which also received investment from British American Tobacco and Snoop Dogg's Casa Verde Capital. Cantourage, a Berlin startup, is the first medical cannabis company listed on the Frankfurt stock exchange.

Portfolio Pulse from Jelena Martinovic

December 01, 2023 | 6:35 pm

CBD of Denver, Inc. (OTCPK: CBDD) partners with Channel 21 in Germany to sell its Magic Lappen via teleshopping. The company reports Q3 sales of $677,893, a significant increase from the previous year, and a reduced net loss from operations. CBDD's stock was down 5.56% at $0.0008 per share.

Portfolio Pulse from Joana Scopel

November 21, 2023 | 8:32 pm

CBD of Denver, Inc. (OTC:CBDD) has announced that its subsidiary, Luxora, is making a move into the European cannabis market by signing four Letters of Intent for the establishment and operation of four Cannabis Clubs in Germany. Luxora is introducing a 'Production Facility Rental Model' to support these clubs, which will supply unique cannabis strains, positioning Luxora for pending German legislation expected to legalize cannabis clubs. CBD of Denver is also repositioning Berliner Innovation and adopting a 'North American-style' social media approach to expand its product offerings in Europe.

Portfolio Pulse from Nicolás Jose Rodriguez

September 14, 2023 | 4:18 pm

CBD of Denver, Inc. (OTC:CBDD) has acquired HOLISTICH GmbH, a Swiss-based company focused on cannabis tissue cultures. This acquisition will allow CBDD to access the European market, particularly in the DACH region (Germany, Austria, and Switzerland). HOLISTICH has a portfolio of over 240 cannabis strains and will add 30 new exclusive strains with the help of Luxora. The acquisition comes after Germany's cabinet approved marijuana legalization in August.

Portfolio Pulse from Jelena Martinovic

September 08, 2023 | 5:05 pm

All corporate logos and prices are for illustrative purposes only and are not a recommendation, an offer to sell, or a solicitation of an offer to buy any security.